Centre says 122 crore doses needed to inoculate 59 crore people in 18-45 age group

Stating that the central government has already taken proactive steps for procurement of other vaccines apart from Covishield and Covaxin, the Centre told the apex court that it has fast tracked the emergency approvals for foreign produced COVID-19 Vaccines that have been granted approval in other countries

The Centre has told the Supreme Court that a total of 122 crore doses of COVID-19 vaccine would be required to vaccinate a population of 59 crore in the age group of 18 to 45 years. In an affidavit filed before the top court, the Centre said vaccination is the topmost priority of the government and all efforts are being made to achieve an objective of 100 per cent vaccination in the shortest time possible keeping the available resources in mind and availability of vaccine doses into consideration. “It is submitted that considering the limited availability of two vaccines which are presently available in India namely Covaxin and Covisheild, it became incumbent upon the government to prioritise vaccination in the most scientific manner. It is submitted that while prioritising vaccination the first priority was towards health workers.